Back to Search
Start Over
MilliporeSigma Opens US$ 65 Million CDMO Facility to Address Demand for Critical Cancer Therapies
- Source :
- PR Newswire. June 23, 2022
- Publication Year :
- 2022
-
Abstract
- Expansion doubles production of the most highly potent active pharmaceutical ingredients (HPAPIs) MilliporeSigma now one of industry's largest manufacturers of these components globally Builds on company's 30 years' CDMO experience [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PR Newswire
- Publication Type :
- News
- Accession number :
- edsgcl.708041272